Inhibition of Influenza A Virus Infection by Fucoidan Targeting Viral Neuraminidase and Cellular EGFR Pathway.
Inhibition of Influenza A Virus Infection by Fucoidan Targeting Viral Neuraminidase and Cellular EGFR Pathway.
复制标题
岩藻依聚糖靶向病毒神经氨酸酶和细胞 EGFR 通路抑制甲型流感病毒感染
DOI:
10.1038/srep40760
复制
发表时间:
2017-01-17
影响因子:
4.6
通讯作者:
Yu G
中科院分区:
文献类型:
--
作者:
Wang W;Wu J;Zhang X;Hao C;Zhao X;Jiao G;Shan X;Tai W;Yu G
Development of novel anti-influenza A virus (IAV) drugs with high efficiency and low toxicity is critical for preparedness against influenza outbreaks. Herein, we investigated the anti-IAV activities and mechanisms of fucoidanin vitroandin vivo. The results showed that a fucoidan KW derived from brown algaeKjellmaniella crassifoliaeffectively blocked IAV infectionin vitrowith low toxicity. KW possessed broad anti-IAV spectrum and low tendency of induction of viral resistance, superior to the anti-IAV drug amantadine. KW was capable of inactivating virus particles before infection and blocked some stages after adsorption. KW could bind to viral neuraminidase (NA) and inhibit the activity of NA to block the release of IAV. KW also interfered with the activation of EGFR, PKCα, NF-κB, and Akt, and inhibited both IAV endocytosis and EGFR internalization in IAV-infected cells, suggesting that KW may also inhibit cellular EGFR pathway. Moreover, intranasal administration of KW markedly improved survival and decreased viral titers in IAV-infected mice. Therefore, fucoidan KW has the potential to be developed into a novel nasal drop or spray for prevention and treatment of influenza in the future.